LeMaitre Vascular/$LMAT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About LeMaitre Vascular
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Ticker
$LMAT
Sector
Primary listing
Employees
651
Headquarters
Website
LMAT Metrics
BasicAdvanced
$2.5B
42.88
$2.52
0.68
$0.80
0.74%
Price and volume
Market cap
$2.5B
Beta
0.68
52-week high
$115.33
52-week low
$71.42
Average daily volume
221K
Dividend rate
$0.80
Financial strength
Current ratio
12.891
Quick ratio
10.812
Long term debt to equity
46.414
Total debt to equity
47.163
Dividend payout ratio (TTM)
31.37%
Interest coverage (TTM)
12.17%
Profitability
EBITDA (TTM)
73.53
Gross margin (TTM)
70.45%
Net profit margin (TTM)
23.13%
Operating margin (TTM)
25.29%
Effective tax rate (TTM)
23.21%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
7.27%
Return on equity (TTM)
15.80%
Valuation
Price to earnings (TTM)
42.881
Price to revenue (TTM)
9.801
Price to book
6.24
Price to tangible book (TTM)
8.33
Price to free cash flow (TTM)
32.85
Free cash flow yield (TTM)
3.04%
Free cash flow per share (TTM)
3.29
Dividend yield (TTM)
0.74%
Forward dividend yield
0.74%
Growth
Revenue change (TTM)
13.53%
Earnings per share change (TTM)
30.57%
3-year revenue growth (CAGR)
15.58%
10-year revenue growth (CAGR)
12.39%
3-year earnings per share growth (CAGR)
39.41%
10-year earnings per share growth (CAGR)
19.62%
3-year dividend per share growth (CAGR)
16.96%
10-year dividend per share growth (CAGR)
17.46%
What the Analysts think about LMAT
Analyst ratings (Buy, Hold, Sell) for LeMaitre Vascular stock.
LMAT Financial Performance
Revenues and expenses
LMAT Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for LeMaitre Vascular stock?
LeMaitre Vascular (LMAT) has a market cap of $2.5B as of March 16, 2026.
What is the P/E ratio for LeMaitre Vascular stock?
The price to earnings (P/E) ratio for LeMaitre Vascular (LMAT) stock is 42.88 as of March 16, 2026.
Does LeMaitre Vascular stock pay dividends?
Yes, the LeMaitre Vascular (LMAT) stock pays dividends to shareholders. As of March 16, 2026, the dividend rate is $0.8 and the yield is 0.74%. LeMaitre Vascular has a payout ratio of 31.37% on a trailing twelve-month basis.
When is the next LeMaitre Vascular dividend payment date?
The next LeMaitre Vascular (LMAT) dividend payment is scheduled for March 26, 2026.
What is the beta indicator for LeMaitre Vascular?
LeMaitre Vascular (LMAT) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.